Rolziracetam
From Wikipedia, the free encyclopedia
 |
|
 |
|
|
Rolziracetam
|
|
| Systematic (IUPAC) name | |
| 2,6,7,8-tetrahydro-1H-pyrrolizine-3,5-dione | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C7H9N2O2 |
| Mol. mass | 139.152 g/mol |
| SMILES | & |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status |
Unscheduled (US) |
| Routes | Oral |
Rolziracetam is a nootropic drug of the racetam family.
Rolziracetam was found to improve performance on a delayed-response task in aged rhesus monkeys. It has a wide margin of safety in animals and has been evaluated for use in cognitively impaired human subjects. [1]
[edit] See also
[edit] References
- ^ Butler DE, Leonard JD, Caprathe BW, L'Italien YJ, Pavia MR, Hershenson FM, Poschel PH, Marriott JG. Amnesia-reversal activity of a series of cyclic imides. Journal of Medicinal Chemistry. 1987 Mar;30(3):498-503.
|
|||||
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
 |
This article about an organic compound is a stub. You can help Wikipedia by expanding it. |
